Kimia Farma Persero Tbk (KAEF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has a cash flow conversion efficiency ratio of 0.018x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp54.66 Billion ≈ $3.20 Million USD) by net assets (Rp3.07 Trillion ≈ $179.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kimia Farma Persero Tbk - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Kimia Farma Persero Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Kimia Farma Persero Tbk for a breakdown of total debt and financial obligations.
Kimia Farma Persero Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kimia Farma Persero Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shriram Properties Limited
NSE:SHRIRAMPPS
|
0.003x |
|
POLARIS RENEWABLE ENERGY
F:N4T
|
N/A |
|
Tofu Restaurant Co Ltd
TWO:2752
|
0.148x |
|
CHOROKBAEM COMPANY Co. Ltd
KQ:052300
|
0.032x |
|
Intelligent Monitoring Group Ltd
AU:IMB
|
0.149x |
|
HyVision System. Inc
KQ:126700
|
-0.033x |
|
Sanara Medtech Inc
NASDAQ:SMTI
|
0.665x |
|
Orion Minerals Ltd
AU:ORN
|
-0.059x |
Annual Cash Flow Conversion Efficiency for Kimia Farma Persero Tbk (2003–2024)
The table below shows the annual cash flow conversion efficiency of Kimia Farma Persero Tbk from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see KAEF stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp3.43 Trillion ≈ $200.91 Million |
Rp153.62 Billion ≈ $9.00 Million |
0.045x | +178.56% |
| 2023-12-31 | Rp6.39 Trillion ≈ $374.59 Million |
Rp-364.58 Billion ≈ $-21.36 Million |
-0.057x | -232.05% |
| 2022-12-31 | Rp9.34 Trillion ≈ $547.25 Million |
Rp403.34 Billion ≈ $23.63 Million |
0.043x | +239.48% |
| 2021-12-31 | Rp7.23 Trillion ≈ $423.76 Million |
Rp-223.92 Billion ≈ $-13.12 Million |
-0.031x | -121.59% |
| 2020-12-31 | Rp7.11 Trillion ≈ $416.36 Million |
Rp1.02 Trillion ≈ $59.71 Million |
0.143x | +157.34% |
| 2019-12-31 | Rp7.41 Trillion ≈ $434.37 Million |
Rp-1.85 Trillion ≈ $-108.63 Million |
-0.250x | -528.82% |
| 2018-12-31 | Rp3.36 Trillion ≈ $196.68 Million |
Rp195.75 Billion ≈ $11.47 Million |
0.058x | +359.68% |
| 2017-12-31 | Rp2.57 Trillion ≈ $150.74 Million |
Rp32.64 Billion ≈ $1.91 Million |
0.013x | -86.50% |
| 2016-12-31 | Rp2.27 Trillion ≈ $133.10 Million |
Rp213.43 Billion ≈ $12.51 Million |
0.094x | -13.74% |
| 2015-12-31 | Rp1.86 Trillion ≈ $109.11 Million |
Rp202.84 Billion ≈ $11.89 Million |
0.109x | -31.09% |
| 2014-12-31 | Rp1.81 Trillion ≈ $106.13 Million |
Rp286.31 Billion ≈ $16.78 Million |
0.158x | +1.18% |
| 2013-12-31 | Rp1.62 Trillion ≈ $95.18 Million |
Rp253.78 Billion ≈ $14.87 Million |
0.156x | -2.34% |
| 2012-12-31 | Rp1.44 Trillion ≈ $84.47 Million |
Rp230.61 Billion ≈ $13.51 Million |
0.160x | +138.80% |
| 2011-12-31 | Rp1.25 Trillion ≈ $73.39 Million |
Rp83.91 Billion ≈ $4.92 Million |
0.067x | -47.21% |
| 2010-12-31 | Rp1.11 Trillion ≈ $65.28 Million |
Rp141.37 Billion ≈ $8.28 Million |
0.127x | +3.52% |
| 2009-12-31 | Rp995.32 Billion ≈ $58.32 Million |
Rp122.01 Billion ≈ $7.15 Million |
0.123x | +504.90% |
| 2008-12-31 | Rp947.76 Billion ≈ $55.54 Million |
Rp-28.69 Billion ≈ $-1.68 Million |
-0.030x | -149.52% |
| 2007-12-31 | Rp908.03 Billion ≈ $53.21 Million |
Rp55.51 Billion ≈ $3.25 Million |
0.061x | -62.05% |
| 2006-12-31 | Rp870.65 Billion ≈ $51.02 Million |
Rp140.24 Billion ≈ $8.22 Million |
0.161x | +344.45% |
| 2005-12-31 | Rp844.22 Billion ≈ $49.47 Million |
Rp30.60 Billion ≈ $1.79 Million |
0.036x | -91.31% |
| 2003-12-31 | Rp754.46 Billion ≈ $44.21 Million |
Rp314.63 Billion ≈ $18.44 Million |
0.417x | -- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as wel… Read more